18F-PSMA-1007 PET/CT for Response Assessment in Patients With mRCC Undergoing Systemic Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
18F-PSMA-1007 PET/CT for Response Assessment in Patients With Metastatic Renal Cell Carcinoma Undergoing Tyrosine Kinase or Checkpoint Inhibitor Therapy: Preliminary Results
Eur. J. Nucl. Med. Mol. Imaging 2020 Dec 28;[EPub Ahead of Print], LM Mittlmeier, M Unterrainer, S Rodler, A Todica, NL Albert, C Burgard, CC Cyran, WG Kunz, J Ricke, P Bartenstein, CG Stief, H Ilhan, M StaehlerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.